Prestige Consumer Healthcare Inc (PBH)
68.38
+0.35
(+0.51%)
USD |
NYSE |
Apr 18, 16:00
68.38
0.00 (0.00%)
After-Hours: 19:52
Prestige Consumer Healthcare Cash from Financing (TTM): -253.07M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -253.07M |
| September 30, 2023 | -198.24M |
| June 30, 2023 | -192.65M |
| March 31, 2023 | -185.85M |
| December 31, 2022 | -159.47M |
| September 30, 2022 | -217.08M |
| June 30, 2022 | -118.59M |
| March 31, 2022 | -7.569M |
| December 31, 2021 | -37.16M |
| September 30, 2021 | 21.43M |
| June 30, 2021 | -104.41M |
| March 31, 2021 | -279.42M |
| December 31, 2020 | -175.15M |
| September 30, 2020 | -221.78M |
| June 30, 2020 | -193.50M |
| March 31, 2020 | -131.43M |
| December 31, 2019 | -196.99M |
| September 30, 2019 | -194.41M |
| June 30, 2019 | -247.24M |
| March 31, 2019 | -249.33M |
| December 31, 2018 | -268.67M |
| September 30, 2018 | -255.58M |
| June 30, 2018 | -209.74M |
| March 31, 2018 | -208.96M |
| December 31, 2017 | 629.84M |
| Date | Value |
|---|---|
| September 30, 2017 | 604.83M |
| June 30, 2017 | 558.36M |
| March 31, 2017 | 560.96M |
| December 31, 2016 | -47.92M |
| September 30, 2016 | -8.799M |
| June 30, 2016 | 46.96M |
| March 31, 2016 | 52.08M |
| December 31, 2015 | -163.32M |
| September 30, 2015 | -191.55M |
| June 30, 2015 | 564.32M |
| March 31, 2015 | 643.26M |
| December 31, 2014 | 596.39M |
| September 30, 2014 | 693.12M |
| June 30, 2014 | 12.70M |
| March 31, 2014 | -41.15M |
| December 31, 2013 | 25.46M |
| September 30, 2013 | -94.26M |
| June 30, 2013 | -141.99M |
| March 31, 2013 | -152.12M |
| December 31, 2012 | 536.09M |
| September 30, 2012 | 595.21M |
| June 30, 2012 | 595.22M |
| March 31, 2012 | 600.43M |
| December 31, 2011 | -75.29M |
| September 30, 2011 | 154.30M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-279.42M
Minimum
Mar 2021
21.43M
Maximum
Sep 2021
-162.77M
Average
-192.65M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |
| iBio Inc | 10.68M |
| Theriva Biologics Inc | 0.625M |
| Ampio Pharmaceuticals Inc | 0.00 |